Key Details
Price
$0.00Annual ROE
-256.90%Beta
-21.80Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
Nov 25, 2024Recent annual earnings:
Mar 29, 2022Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Sept 12, 2023Analyst ratings
Recent major analysts updates
24 Mar '22 Alliance Global Partners
Buy19 Dec '19 Roth Capital
Buy22 Aug '14 Jefferies
Hold27 June '14 Jefferies
Buy01 Mar '13 Aegis Capital
BuyMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Ampio Pharmaceuticals doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
3 Biotech Stocks to Buy With Explosive Upside Potential
AMPE
InvestorPlace22 June 2023
The biotech sector will always house stocks with explosive upside potential. The very nature of the sector ensures that will continue to be the case.
FAQ
- What is the primary business of Ampio Pharmaceuticals?
- What is the ticker symbol for Ampio Pharmaceuticals?
- Does Ampio Pharmaceuticals pay dividends?
- What sector is Ampio Pharmaceuticals in?
- What industry is Ampio Pharmaceuticals in?
- What country is Ampio Pharmaceuticals based in?
- When did Ampio Pharmaceuticals go public?
- Is Ampio Pharmaceuticals in the S&P 500?
- Is Ampio Pharmaceuticals in the NASDAQ 100?
- Is Ampio Pharmaceuticals in the Dow Jones?
- When was Ampio Pharmaceuticals's last earnings report?
- When does Ampio Pharmaceuticals report earnings?
- Should I buy Ampio Pharmaceuticals stock now?
What is the primary business of Ampio Pharmaceuticals?
Ampio Pharmaceuticals focuses on developing innovative therapies for inflammatory and degenerative diseases. Their main product, Ampion, aims to treat conditions like osteoarthritis. The company emphasizes research and clinical trials to bring new treatments to patients, improving their quality of life.
What is the ticker symbol for Ampio Pharmaceuticals?
The ticker symbol for Ampio Pharmaceuticals is NYSE American:AMPE
Does Ampio Pharmaceuticals pay dividends?
No, Ampio Pharmaceuticals does not pay dividends
What sector is Ampio Pharmaceuticals in?
Ampio Pharmaceuticals is in the Healthcare sector
What industry is Ampio Pharmaceuticals in?
Ampio Pharmaceuticals is in the Biotechnology industry
What country is Ampio Pharmaceuticals based in?
Ampio Pharmaceuticals is headquartered in United States
When did Ampio Pharmaceuticals go public?
Ampio Pharmaceuticals's initial public offering (IPO) was on 31 March 2010
Is Ampio Pharmaceuticals in the S&P 500?
No, Ampio Pharmaceuticals is not included in the S&P 500 index
Is Ampio Pharmaceuticals in the NASDAQ 100?
No, Ampio Pharmaceuticals is not included in the NASDAQ 100 index
Is Ampio Pharmaceuticals in the Dow Jones?
No, Ampio Pharmaceuticals is not included in the Dow Jones index
When was Ampio Pharmaceuticals's last earnings report?
Ampio Pharmaceuticals's most recent earnings report was on 25 November 2024
When does Ampio Pharmaceuticals report earnings?
The date for Ampio Pharmaceuticals's next earnings report has not been announced yet
Should I buy Ampio Pharmaceuticals stock now?
As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions